Society guideline links: Treatment and prevention of seasonal influenza with antivirals

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Seasonal influenza vaccination".)

Canada

●Association of Medical Microbiology and Infectious Disease (AMMI) Canada: Use of antiviral drugs for seasonal influenza – Foundation document for practitioners, update (2019)

●Canadian Paediatric Society (CPS): Practice point on the use of antiviral drugs for influenza – Guidance for practitioners (2018)

United States

●American Academy of Pediatrics (AAP): Recommendations for prevention and control of influenza in children, 2023-2024 (2023)

•Technical report (2023)

●AAP: Red Book – Influenza (2023)

●Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD): Influenza antiviral medications – Summary for clinicians (2022)

●American College of Obstetricians and Gynecologists (ACOG): Committee opinion on the assessment and treatment of pregnant women with suspected or confirmed influenza (2018, reaffirmed 2021)

●American Society of Transplantation (AST): Guidelines on RNA respiratory viral infections in solid organ transplant recipients (2019)

●Infectious Diseases Society of America (IDSA): Clinical practice guidelines on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza, update (2018)